A Study of Blood and Tissue Samples to Measure Immune Responses to Melanoma
About this study
The purpose of this study is to collect blood and tissue samples to measure immune responses to melanoma.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Patients undergoing a clinically-indicated core needle biopsy for suspected melanoma recurrence
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
|Mayo Clinic Location
Mayo Clinic principal investigator
Matthew Block, M.D., Ph.D.
Closed for enrollment
Cancer Center Clinical Trials Referral Office